PDE4C and central nervous system cancer: As a potential prognostic biomarker in human glioma whose incidence increases with age36, PDE4C exhibited promoter hypermethylation in high-grade glioma samples and hypomethylation in low-grade glioma samples with the reverse expression levels37, which suggests the potential correlation between PDE4C and age.